Evidence map›Paper›PMID 34203917›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Rapid and Accurate Detection of

Isidoro López, Fátima Otero, Rebeca Guillén, María Del Carmen Fernández, Germán Bou, Jaime Gosálvez, José Luis Fernández

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 63% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Isidoro LópezGenetics Unit, INIBIC-Complejo Hospitalario Universitario A Coruña (CHUAC), 15006 A Coruña, Spain.
Fátima OteroGenetics Unit, INIBIC-Complejo Hospitalario Universitario A Coruña (CHUAC), 15006 A Coruña, Spain.
Rebeca GuillénGenetics Unit, INIBIC-Complejo Hospitalario Universitario A Coruña (CHUAC), 15006 A Coruña, Spain.
María Del Carmen FernándezMicrobiology Division, INIBIC-Complejo Hospitalario Universitario A Coruña (CHUAC), 15006 A Coruña, Spain.
Germán BouMicrobiology Division, INIBIC-Complejo Hospitalario Universitario A Coruña (CHUAC), 15006 A Coruña, Spain.
Jaime GosálvezGenetics Unit, Facultad de Biología, Universidad Autónoma de Madrid, 28049 Madrid, Spain.
José Luis FernándezGenetics Unit, INIBIC-Complejo Hospitalario Universitario A Coruña (CHUAC), 15006 A Coruña, Spain.ORCID 0000-0002-2985-7169
Centro Oncológico de Galicia · ESComplexo Hospitalario Universitario A Coruña · ESUniversidad Autónoma de Madrid · ES

Funding

Innovative Medicines Initiative ND4BBInstituto de Salud Carlos III PI20/01263Instituto de Salud Carlos III RD16/0016/0006
6 · The paper itself

Abstract

Trimethoprim-sulfamethoxazole is a well-known antibiotic that inhibits folic acid synthesis, a topic of renewed interest. Since resistant strains are increasingly more common, an early and accurate discrimination of susceptibility may assure confident therapy. Two morphological assays were performed in

Indexed as

antibiotic resistancecell lengthcotrimoxazoleGram-negativerapid assaytrimethoprim-sulfamethoxazole

Identifiers

PMID34203917
PMCPMC8232604
OpenAlexW3168669537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.